Article R5121-51-6
At the end of the procedures provided for in this sub-section, the marketing authorisation is issued or varied by the Director General of the Agence nationale de sécurité du médicament et des produits…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 4581–4590 of 21427 articles for “Art. Cass. com. 31 March 2004”
At the end of the procedures provided for in this sub-section, the marketing authorisation is issued or varied by the Director General of the Agence nationale de sécurité du médicament et des produits…
For the purposes of placing a custom-made medical device on the market, the manufacturer shall follow the procedure defined in Article R. 5211-51. The Director General of the Agence nationale de sécur…
Presenting medical devices that do not comply with the provisions of articles R. 5211-12 and R. 5211-17 at scientific or technical meetings, exhibitions or demonstrations without displaying a sign cle…
…a view to their acceptance, recognition and enforcement abroad pursuant to:- Regulation (EC) No 805/2004 of the European Parliament and of the Council of 21 April 2004 creating a European Enforcement…
…tenariat in accordance with the procedures specified by the general regulations of the Autorité des marchés financiers.
…t company's decisions concerning the scheme are lawful. The General Regulations of the Autorité des marchés financiers shall specify the terms and conditions for the application of this I, in particul…
Any investment service provider other than a portfolio management company whose registered office is located in mainland France, Guadeloupe, French Guiana, Martinique, La Réunion, Mayotte and Saint-Ma…
The Director General of the Agence nationale de sécurité du médicament et des produits de santé may prohibit the prescription and supply of a proprietary medicinal product and withdraw it from the mar…
When an application for authorisation concerns a generic veterinary medicinal product of a reference veterinary medicinal product which has not been authorised in France but which has been authorised…
For the implementation of the monitoring and alert system mentioned in article L. 5312-4, the Agence nationale de sécurité du médicament et des produits de santé is responsible for receiving and proce…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More